Allure on MSN

I Thought It Was Acne. Turns Out, It Was Lupus.

But it’s an important detail, along with the fact that I’ve been a beauty journalist for nearly seven years—which means I know my skin, and I know when something is off. So when a spot arrived in the ...

Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data of ZORYVE® (roflumilast) Foam 0.3% in Individuals with Seborrheic Dermatitis in American Journal ...

ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis up to 52 weeksOnce-daily ZORYVE foam 0.3% is approved ...

Bristol Myers reaches $239 million settlement over psoriasis, MS drugs

Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded about prospects for the psoriasis drug Otezla, and multiple sclerosis treatment now ...
News-Medical.Net on MSN

Study reveals key role of sugars in immune cell movement during psoriasis

New research has updated our understanding of how sugars, known as glycans, help immune cells move into skin in the ...